3/27/2014 Elite Pharmaceuticals Appoints Barbara Ellison as Vice President of Quality Operations and Regulatory Affairs - New Hire Brings Track Record of Success . 3/24/2014 Elite Pharmaceuticals Announces Supplemental Application for Site Transfer of Isradipine . 3/10/2014 Elite Pharmaceuticals Expands Abuse Deterrent Technology Patent Portfolio Internationally . 3/5/2014 Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse Deterrent Product ELI-200 . 2/18/2014 Elite Pharmaceuticals Reports Results of Pilot Bioequivalence Study for ELI-201. ...We are delighted with the results from our clinical studies and pleased to have confirmation of the formulation for our extended release product. . 1/14/2014 Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Second Opioid Abuse Deterrent Product . 12/5/2013 Elite Pharmaceuticals Initiates Pilot Bioequivalence Study for ELI-201 . 11/14/2013 Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2014 ...Revenues Increase by 83%, Product Development Accelerating
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.